The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes.
Saved in:
| Title: | The tetravalent, bispecific properties of FS118, an anti-LAG-3/PD-L1 antibody, mediate LAG-3 shedding from CD4 + and CD8 + tumor-infiltrating lymphocytes. |
|---|---|
| Authors: | Reader CS; invoX Pharma., Liao W; F-star Therapeutics, Cambridge, UK., Potter-Landua BJ; invoX Pharma., Veyssier CS; invoX Pharma., Seal CJ; invoX Pharma., Brewis N; F-star Therapeutics, Cambridge, UK., Morrow M; invoX Pharma. |
| Source: | Anti-cancer drugs [Anticancer Drugs] 2025 Jul 01; Vol. 36 (6), pp. 447-458. Date of Electronic Publication: 2025 Mar 03. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: England NLM ID: 9100823 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1473-5741 (Electronic) Linking ISSN: 09594973 NLM ISO Abbreviation: Anticancer Drugs Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
